Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 13Gastritis, Atrophic 7Barrett Esophagus 6Colorectal Neoplasms 5Esophageal Neoplasms 4Peptic Ulcer 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Adenomatous Polyposis Coli 2Adenocarcinoma Of Esophagus 2Tuberculosis 1Stomach Ulcer 1Pancreatitis, Chronic 1Pancreatic Neoplasms 1Lymphatic Metastasis 1Liver Neoplasms 1Liver Cirrhosis 1Influenza, Human 1Inflammatory Bowel Diseases 1Head and Neck Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Communicable Diseases 1Cholangiocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Hepatocellular 1Anemia, Iron-Deficiency 1Anemia 1Adenoma 1

Interventions

Cisplatin 116Radiotherapy 84Paclitaxel 77Fluorouracil 62Carboplatin 41Drug Therapy 38pembrolizumab 33Irinotecan 33tislelizumab 27Docetaxel 26Neoadjuvant Therapy 24Oxaliplatin 23toripalimab 22sintilimab 19camrelizumab 19Radiation 19Esophagectomy 18Capecitabine 17130-nm albumin-bound paclitaxel 17Surgical Procedures, Operative 16Nivolumab 16Leucovorin 15Cetuximab 14TP protocol 12S 1 (combination) 12Radiotherapy, Intensity-Modulated 12Albumin-Bound Paclitaxel 12nimotuzumab 11apatinib 10Immune Checkpoint Inhibitors 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Squamous Cell Carcinoma × Gastroscopy × Clear all
NCT07016737 2025-06-12

ESO-Nanjing12

Jiangsu Cancer Institute & Hospital

Phase 3 Enrolling by invitation
79 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04425122 2023-02-08

The Microbiome of Oesophageal Squamous Cell Carcinoma

Chinese University of Hong Kong

Unknown
200 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Communicable Diseases, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡